New study finds that lixisenatide in the retina and the optic nerve head in type 2 diabetes patients may show promise for treating diabetic retinopathy before its clinical manifestation, reports a new study.
from Medindia Health News https://ift.tt/2Y9UUHm
No comments
Thanks for comment via will connect you within 24 hours.